LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 657 participants.
Also called NCT01628159
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 657 participants
- Sponsor
- Registry
-
NCT01628159
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, Belgium, Germany, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT01628159. Allocation not applicable; no masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2018-09 (actual). Results posted on 2020-04-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)
- Condition
- Peripheral Artery Disease
- Intervention (Device)
- Lutonix Drug Coated Balloon
- Lead sponsor
- C. R. Bard
Record details
- Record id
cardio:ct-nct01628159- Content hash
2d0b2ec3aa354fe8c7acb0447d12504d2c62b448c89788c0a86264e957f64641